12/4
02:00 pm
regn
Rating for REGN
Low
Report
Rating for REGN
12/4
09:00 am
regn
Rating for REGN
Low
Report
Rating for REGN
12/4
09:00 am
regn
Rating for REGN
Low
Report
Rating for REGN
12/3
10:27 am
regn
Rating for REGN
Low
Report
Rating for REGN
12/3
10:27 am
regn
Rating for REGN
Low
Report
Rating for REGN
12/3
08:44 am
regn
Regeneron Pharmaceuticals (NASDAQ:REGN) was downgraded by analysts at Morgan Stanley from an "overweight" rating to an "equal weight" rating. They now have a $767.00 price target on the stock.
Low
Report
Regeneron Pharmaceuticals (NASDAQ:REGN) was downgraded by analysts at Morgan Stanley from an "overweight" rating to an "equal weight" rating. They now have a $767.00 price target on the stock.
12/3
08:44 am
regn
Regeneron Pharmaceuticals (NASDAQ:REGN) was downgraded by analysts at Morgan Stanley from an "overweight" rating to an "equal weight" rating. They now have a $767.00 price target on the stock.
Low
Report
Regeneron Pharmaceuticals (NASDAQ:REGN) was downgraded by analysts at Morgan Stanley from an "overweight" rating to an "equal weight" rating. They now have a $767.00 price target on the stock.
12/3
05:05 am
regn
Regeneron downgraded to Equal Weight from Overweight at Morgan Stanley
Low
Report
Regeneron downgraded to Equal Weight from Overweight at Morgan Stanley
12/3
05:05 am
regn
Regeneron downgraded to Equal Weight from Overweight at Morgan Stanley
Low
Report
Regeneron downgraded to Equal Weight from Overweight at Morgan Stanley
11/24
10:01 am
regn
Rating for REGN
Low
Report
Rating for REGN
11/24
10:01 am
regn
Rating for REGN
Low
Report
Rating for REGN
11/24
08:06 am
regn
Regeneron Pharmaceuticals (NASDAQ:REGN) is now covered by analysts at HSBC Holdings plc. They set a "buy" rating and a $890.00 price target on the stock.
Low
Report
Regeneron Pharmaceuticals (NASDAQ:REGN) is now covered by analysts at HSBC Holdings plc. They set a "buy" rating and a $890.00 price target on the stock.
11/24
06:09 am
regn
Rating for REGN
Low
Report
Rating for REGN
11/24
06:09 am
regn
Rating for REGN
Low
Report
Rating for REGN
11/24
04:47 am
regn
Regeneron initiated with a Buy at HSBC
Low
Report
Regeneron initiated with a Buy at HSBC
11/24
04:47 am
regn
Regeneron initiated with a Buy at HSBC
Low
Report
Regeneron initiated with a Buy at HSBC
11/20
10:39 am
regn
Rating for REGN
Low
Report
Rating for REGN
11/20
10:39 am
regn
Rating for REGN
Low
Report
Rating for REGN
11/14
07:53 am
regn
Regeneron Pharmaceuticals (NASDAQ:REGN) was upgraded by analysts at Scotiabank to a "hold" rating.
Low
Report
Regeneron Pharmaceuticals (NASDAQ:REGN) was upgraded by analysts at Scotiabank to a "hold" rating.
11/14
07:53 am
regn
Regeneron Pharmaceuticals (NASDAQ:REGN) was upgraded by analysts at Scotiabank to a "hold" rating.
Low
Report
Regeneron Pharmaceuticals (NASDAQ:REGN) was upgraded by analysts at Scotiabank to a "hold" rating.
11/13
09:53 am
regn
Regeneron Pharmaceuticals (NASDAQ:REGN) is now covered by analysts at Scotiabank. They set a "sector perform" rating and a $650.00 price target on the stock.
Low
Report
Regeneron Pharmaceuticals (NASDAQ:REGN) is now covered by analysts at Scotiabank. They set a "sector perform" rating and a $650.00 price target on the stock.
11/13
09:53 am
regn
Regeneron Pharmaceuticals (NASDAQ:REGN) is now covered by analysts at Scotiabank. They set a "sector perform" rating and a $650.00 price target on the stock.
Low
Report
Regeneron Pharmaceuticals (NASDAQ:REGN) is now covered by analysts at Scotiabank. They set a "sector perform" rating and a $650.00 price target on the stock.
11/12
04:19 pm
regn
Regeneron initiated with a Sector Perform at Scotiabank
Low
Report
Regeneron initiated with a Sector Perform at Scotiabank
11/12
04:19 pm
regn
Regeneron initiated with a Sector Perform at Scotiabank
Low
Report
Regeneron initiated with a Sector Perform at Scotiabank
11/7
12:51 pm
regn
Rating for REGN
Low
Report
Rating for REGN